Equibles does not estimate personal net worth.
Get an email with a short summary when Caris Life Sciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get CAI alertsDavid Dean Halbert is recorded as CEO at Caris Life Sciences, Inc. (CAI). The newest filing on record that lists David Dean Halbert as CEO at Caris Life Sciences, Inc. (CAI) is dated April 23, 2026. The proxy statement of Caris Life Sciences, Inc. reports total compensation of $20,350,571 for David Dean Halbert in fiscal 2025, including a base salary of $764,918. Disclosed compensation is on record for 2 fiscal years. David Dean Halbert has spoken on 4 earnings calls across 1 company, most recently for Caris Life Sciences, Inc. on November 4, 2026. Caris Life Sciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Caris Life Sciences, Inc. includes Jeffrey Vacirca (CEO), Brian J. Brille (Chairman), Jon S. Halbert (Chairman) and 5 others.
“This was another record quarter for us with volume of 21% to 61,500 cases, and our revenue grew 27% to 275 million. What I like most about these numbers is that they are the continued result of a plan.”
“This is a strong start to the year and we're pleased to report continued growth, profitability, and cash generation, which will continue to support our investment strategy focused on MSED launch, the broader product pipeline, and commercial platform expanded.”
“And thank you all for joining our fourth quarter 2025 earnings call.”
Start not stated–present
Last confirmed April 23, 2026
Biotechnology · Healthcare
CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Caris Life Sciences, Inc. (CAI) | Chief Executive Officer | $764,918 | $20,350,571 |
| 2024 | Caris Life Sciences, Inc. (CAI) | Chief Executive Officer | $750,000 | $2,250,000 |
